Stago's 2024 CSR report is online
The Stago Group is strengthening its commitment to Corporate Social Responsibility (CSR) and publishing its first 2024 report.
Read moreStago's 2024 CSR report is online
The Stago Group is strengthening its commitment to Corporate Social Responsibility (CSR) and publishing its first 2024 report.
Read moreCOVID-19 infection and thrombotic disorders
Since December 2019, COVID-19 is spreading worldwide and affecting people every day.
Main symptoms are fever and cough, and most of patients recover spontaneously.
However, about 1 in 6 patients can develop breathing difficulties and in some of them the disease progresses to a more systemic disease and multiple organ dysfunction (1). Patient’s risk stratification is key to optimize COVID-19 patients flow at hospital. Stratification is currently based on characteristics of severe pneumonia and on laboratory findings.
Read moreSetting the standard with exclusive mechanical technology built into all Stago systems for more than 30 years, Stago’s Viscosity-Based Detection System consistently delivers the right result, the first time.
Read moreCovid 19 impact on Stago’s range
As part of our commitment to healthcare, Stago has been closely monitoring the development of Covid 19 worldwide, implementing several actions in the past few weeks.
Read moreHealth Economics Outcomes evaluation of Stago D-dimer
Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Read more